| Entry |
|
| Name |
Rifamycins |
| Class |
|
| Pathway map |

|
| Compound |
| D00424 | Rifabutin (JAN/USP/INN) |
| D02554 | Rifaximin (JAN/USAN/INN) |
| D08480 | Rifamycin sodium (USAN) |
|
| Reference |
|
| Authors |
Fukai S. |
| Title |
[New Drugs Today (6th ed)] (In Japanese) |
| Journal |
Jiho (1995) |
| Reference |
|
| Authors |
David AW, Thomas LL, William OF. |
| Title |
Foye's Principles of Medicinal Chemistry (5th ed) |
| Journal |
Lippincott Williams & Wilkins (2002) |
| Reference |
|
| Authors |
Hardman JG, Limbird LE, Gilman AG (eds). |
| Title |
Goodman & Gilman's The Pharmacological Basis of Therapeutics (10th ed) |
| Journal |
McGraw-Hill (2001) |
| Reference |
|
| Authors |
Walter S. |
| Title |
Drug Discovery: A History |
| Journal |
Wiley (2005) |
| Reference |
|
| Authors |
Saito H, Tomioka H, Sato K, Emori M, Yamane T, Yamashita K, Hosoe K, Hidaka T |
| Title |
In vitro antimycobacterial activities of newly synthesized benzoxazinorifamycins. |
| Journal |
|
| Reference |
|
| Authors |
Heifets L, Sanchez T, Vanderkolk J, Pham V |
| Title |
Development of rifapentine susceptibility tests for Mycobacterium tuberculosis. |
| Journal |
|
| Reference |
|
| Authors |
Floss HG, Yu TW. |
| Title |
Rifamycin-mode of action, resistance, and biosynthesis. |
| Journal |
|
Related pathway |
|